401 Epizód

  1. Episode 203: Renee Saliby in the Rising Star series

    Közzétéve: 2022. 11. 14.

  2. Episode 202: The Uromigos Paper of the Month - Docetaxel with or without continuous enza in CRPC

    Közzétéve: 2022. 11. 07.

  3. Episode 201: PARPi in CRPC

    Közzétéve: 2022. 11. 01.

  4. Episode 200: Chromophobe renal cancer

    Közzétéve: 2022. 10. 25.

  5. Episode 199: The Uromigos Paper of the Month - FGFR inhibition in bladder cancer

    Közzétéve: 2022. 10. 17.

  6. Episode 198: The RADICALS trial in prostate cancer

    Közzétéve: 2022. 10. 07.

  7. Episode 197: The Uromigos Nashville 2022

    Közzétéve: 2022. 09. 29.

  8. Episode 196: The COSMIC-313 Trial cabo/ipi/nivo in 1st line renal cancer

    Közzétéve: 2022. 09. 14.

  9. Episode 195 ESMO 2022: EV Pembrolizumab in 1st line bladder cancer

    Közzétéve: 2022. 09. 13.

  10. Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer

    Közzétéve: 2022. 09. 12.

  11. Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer

    Közzétéve: 2022. 09. 11.

  12. Episode 192 ESMO 2022: Summary of ESMO Adjuvant RCC Trials

    Közzétéve: 2022. 09. 11.

  13. Episode 191 ESMO 2022: PROSPER study of neoadjuvant nivolumab in RCC

    Közzétéve: 2022. 09. 10.

  14. Episode 190: ESMO 2022 Preview

    Közzétéve: 2022. 09. 02.

  15. Episode 189: The Uromigos Paper of the Month - Robotic vs open cystectomy

    Közzétéve: 2022. 08. 22.

  16. Episode 188: The 1st Uromigos Live and Unplugged face-to-face meeting

    Közzétéve: 2022. 08. 15.

  17. Episode 187: Cora Sternberg - The Uromigos Legends Series

    Közzétéve: 2022. 08. 15.

  18. Episode 186: Bernard Escudier - The Uromigos Legends Series

    Közzétéve: 2022. 08. 10.

  19. Episode 185: The Uromigos Paper of the Month - ctDNA in prostate cancer

    Közzétéve: 2022. 08. 01.

  20. Episode 184: Active surveillance in prostate cancer and the seeds of doubt

    Közzétéve: 2022. 07. 26.

11 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site